Perioperative neutrophil: Lymphocyte ratio and postoperative NSAID use as predictors of survival after lung cancer surgery: A retrospective study

Cancer Medicine

Volumn 4, Issue 6, 2015, Pages 825-833

  Choi, Jae Eun ^a   Villarreal, John ^b   Lasala, Javier ^b   Gottumukkala, Vijaya ^b   Mehran, Reza J ^b   Rice, David ^b   Yu, Jun ^b   Feng, Lei ^b   Cata, Juan P ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c OUTCOMES RESEARCH CONSORTIUM   (United States)

Author keywords

Anti inflammatory agents, nonsteroidal; Neoplasms; Non small cell lung cell, surgery, inflammation

Indexed keywords

CELECOXIB; IBUPROFEN; KETOROLAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DRUG USE; FEMALE; HUMAN; LUNG CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL LYMPHOCYTE RATIO; OVERALL SURVIVAL; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TUMOR RECURRENCE; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE FREE SURVIVAL; LEUKOCYTE COUNT; LUNG NEOPLASMS; LYMPHOCYTE; MIDDLE AGED; MORTALITY; NEUTROPHIL; PEROPERATIVE CARE; PHYSIOLOGY; PROCEDURES; TUMOR MICROENVIRONMENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INTRAOPERATIVE CARE; LEUKOCYTE COUNT; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPHILS; RETROSPECTIVE STUDIES; TUMOR MICROENVIRONMENT;

EID: 85006218750     PISSN: None     EISSN: 20457634     Source Type: Journal    
DOI: 10.1002/cam4.428     Document Type: Article

References (22)

1. Siegel, R., J. Ma, Z. Zou, and A. Jemal . 2014. Cancer statistics, 2014. CA Cancer J. Clin. 64:9-29.
2. Siegel, R., C. DeSantis, K. Virgo, K. Stein, A. Mariotto, T. Smith, et al. 2012. Cancer treatment and survivorship statistics, 2012. CA Cancer J. Clin. 62:220-241.
3. Balkwill, F., and A. Mantovani . 2001. Inflammation and cancer: back to Virchow? Lancet 357:539-545.
4. Forget, P., and M. De Kock . 2014. Perspectives in anaesthesia for cancer surgery. J. Cancer Res. Clin. Oncol. 140:353-359.
5. Templeton, A. J., M. G. McNamara, B. Šeruga, F. E. Vera-Badillo, P. Aneja, A. Ocaña, et al. 2014. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J. Natl. Cancer Inst. 106 (6):dju124.
6. Bugada, D., M. Allegri, P. Lavand'homme, M. De Kock, and G. Fanelli . 2014. Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients. Biomed. Res. Int. 2014:142425.
7. Pinato, D. J., R. J. Shiner, M. J. Seckl, J. Stebbing, R. Sharma, and F. A. Mauri . 2014. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Br. J. Cancer 110:1930-1935.
8. Forget, P., J. P. Machiels, P. G. Coulie, M. Berliere, A. J. Poncelet, B. Tombal, et al. 2013. Neutrophil:lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery. Ann. Surg. Oncol. 20(Suppl. 3):S650-S660.
9. Gomez, D., S. Farid, H. Z. Malik, A. L. Young, G. J. Toogood, J. P. Lodge, et al. 2008. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J. Surg. 32:1757-1762.
10. Yuan, D., K. Zhu, K. Li, R. Yan, Y. Jia, and C. Dang . 2014. The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction. J. Surg. Oncol. 110:333-340.
11. Zhang, S., L. Da, X. Yang, D. Feng, R. Yin, M. Lin, et al. 2014. Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated beta-catenin pathway. Toxicol. Lett. 225:201-207.
12. Benish, M., I. Bartal, Y. Goldfarb, B. Levi, R. Avraham, A. Raz, et al. 2008. Perioperative use of beta-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann. Surg. Oncol. 15:2042-2052.
13. Glasner, A., R. Avraham, E. Rosenne, M. Benish, O. Zmora, S. Shemer, et al. 2010. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J. Immunol. 184:2449-2457.
14. Sarraf, K. M., E. Belcher, E. Raevsky, A. G. Nicholson, P. Goldstraw, and E. Lim . 2009. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 137:425-428.
15. Tomita, M., T. Shimizu, T. Ayabe, K. Nakamura, and T. Onitsuka . 2012. Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer. Anticancer Res. 32:3535-3538.
16. Tomita, M., T. Shimizu, T. Ayabe, A. Yonei, and T. Onitsuka . 2011. Preoperative neutrophil to lymphocyte ratio as a prognostic predictor after curative resection for non-small cell lung cancer. Anticancer Res. 31:2995-2998.
17. Stephens, N., D. Rice, A. Correa, W. Hoffstetter, R. Mehran, J. Roth, et al. 2014. Thoracoscopic lobectomy is associated with improved short-term and equivalent oncological outcomes compared with open lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis of 963 cases. Eur. J. Cardiothorac. Surg. 46:607-613.
18. Jones, R. O., N. H. Anderson, J. T. Murchison, M. Brittan, E. J. Simon, G. Casali, et al. 2014. Innate immune responses after resection for lung cancer via video-assisted thoracoscopic surgery and thoracotomy. Innovations (Phila). 9:93-103; discussion 103.
19. Forget, P., and M. De Kock . 2014. Important data about anaesthetics and cancer recurrence. Acta Anaesthesiol. Scand. 58:371-372.
20. Forget, P., C. Bentin, J. P. Machiels, M. Berliere, P. G. Coulie, and M. De Kock . 2014. Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery. Br. J. Anaesth. 113(suppl. 1):i82-7.
21. Forget, P., J. Vandenhende, M. Berliere, J. P. Machiels, B. Nussbaum, C. Legrand, M. De Kock, et al. 2010. Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth. Analg. 110:1630-1635.
22. Concato, J., A. R. Feinstein, and T. R. Holford . 1993. The risk of determining risk with multivariable models. Ann. Intern. Med. 118:201-210.